Engrail Therapeutics Secures $157 Million in Funding to Advance Pipeline

Engrail Therapeutics, a San Diego-headquartered company focused on neurological and mental health conditions, has secured $157 million in Series B funding. This significant investment round will fuel the advancement of… Continue reading Engrail Therapeutics Secures $157 Million in Funding to Advance Pipeline